World’s first Malaria Vaccine Submitted for Approval to EMA

GlaxoSmithKline submits the first malaria vaccine for approval by the European Medicines Agency and the World Health Organization The vaccine, named RTS,S, targets Plasmodium falciparumĀ parasite. This parasite is most commonly found in sub-Saharan, where 90% of malaria related deaths occur. Children under 5 account for 77% of the deaths. The vaccine uses the AS01 adjuvant system, and works by preventing …